This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Feasibility of Physical Activity in Advanced Cancer Patients

This study has been completed.
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta Identifier:
First received: February 20, 2007
Last updated: February 24, 2016
Last verified: January 2012
Physical activity has been shown to have a positive effect on several quality of life outcomes in cancer patients, but few existing studies have focused on the end stages of cancer. The aim of this pilot study is to test the feasibility of a physical activity intervention in advanced cancer patients, from which data can be used to design a randomized controlled trial if results are encouraging.

Condition Intervention
Advanced Cancer Behavioral: Home-based physical activity program

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Pilot Study to Explore the Role of Physical Activity as a Quality of Life Intervention in Advanced Cancer Patients

Resource links provided by NLM:

Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 30
Study Start Date: October 2006
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Home-based physical activity program
    the role of physical activity as a Quality of Life intervention
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Advanced Cancer Patients

Inclusion Criteria:

  • 18 years of age or older
  • able to understand, provide written consent in and speak English
  • cognitive ability to participate
  • clinician-estimated life expectancy between 3 and 12 months
  • approval of treating physician

Exclusion Criteria:

  • any absolute contraindications to physical activity
  • palliative performance scale level of 30% of less
  • any patient within the last days to hour of life
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00438620

Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Cross Cancer Institute
Study Chair: Kerry Courneya, PhD AHS Cancer Control Alberta
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: AHS Cancer Control Alberta Identifier: NCT00438620     History of Changes
Other Study ID Numbers: PS-08-0054
Study First Received: February 20, 2007
Last Updated: February 24, 2016

Additional relevant MeSH terms:
Neoplasms processed this record on August 22, 2017